GAITHERSBURG, Md.--In a three-part deal Gene Logic has agreed to license NeuralStem BioPharmaceuticals' human central nervous system stem cell technology for gene expression analysis and for inclusion in Gene Logic's GeneExpress database. NeuralStem has bought a GeneExpress module and Gene Logic has made an equity investment in NeuralStem. Financial terms of the agreement were not disclosed.
Gene Logic to Add Stem Cell Data to GeneExpress
May 18, 2000